Fennec Pharmaceuticals (FENC) Debt to Equity (2010 - 2022)
Fennec Pharmaceuticals posted quarterly Debt to Equity of $8.92 for Q3 2022, up 1424.09% on a QoQ basis from $0.59 in Q2 2022.
Fennec Pharmaceuticals (FENC) has 10 years of Debt to Equity data on file, last reported at $8.92 in Q3 2022.
- For the quarter ending Q3 2022, Debt to Equity changed N/A year-over-year to $8.92; the trailing twelve-month figure through Sep 2022 stood at $8.92 (changed N/A YoY), and the FY2021 full-year result was $0.32, changed N/A from the prior year.
- Debt to Equity for Q3 2022 stood at $8.92, up from $0.59 in the prior quarter.
- Across five years, Debt to Equity topped out at $8.92 in Q3 2022 and bottomed at $0.32 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.06 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 8.92 |
| Jun 30, 2022 | 0.59 |
| Mar 31, 2022 | 0.40 |
| Dec 31, 2021 | 0.32 |
| Dec 31, 2017 | 6.24 |
| Sep 30, 2017 | 0.04 |
| Jun 30, 2017 | 0.02 |
| Mar 31, 2017 | 0.02 |
| Dec 31, 2016 | 0.01 |
| Sep 30, 2016 | 0.01 |
| Jun 30, 2016 | 0.01 |
| Mar 31, 2016 | 0.16 |
| Dec 31, 2015 | 0.15 |
| Sep 30, 2015 | 0.09 |
| Jun 30, 2015 | 0.28 |
| Mar 31, 2015 | 0.84 |
| Dec 31, 2014 | 2.15 |
| Sep 30, 2014 | -1.08 |
| Jun 30, 2014 | -1.15 |
| Mar 31, 2014 | -1.27 |
| Dec 31, 2013 | -1.97 |
| Sep 30, 2013 | -1.06 |
| Jun 30, 2013 | -1.10 |
| Mar 31, 2013 | -1.13 |
| Dec 31, 2012 | -1.34 |
| Sep 30, 2012 | 0.97 |
| Jun 30, 2012 | 0.54 |
| Mar 31, 2012 | 0.67 |
| Dec 31, 2011 | -42.31 |
| Sep 30, 2011 | -2.58 |
| Jun 30, 2011 | -10.59 |
| Dec 31, 2010 | -2.12 |